CD56‐positive cancers, such as small‐cell lung carcinoma, mesothelioma, carcinoid tumours, islet cell tumours and tumours with NE differentiation, are more aggressive than CD56‐negative cancers.33, 34, 35. Here, NCAM1 is linked to digestive system neuroendocrine neoplasm.